# Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy

> **NCT04216849** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Shanghai East Hospital** · enrollment: 54 (estimated)

## Conditions studied

- Type 2 Diabetes With Renal Manifestations

## Interventions

- **BIOLOGICAL:** human umbilical cord mesenchymal stem cells
- **OTHER:** saline

## Key facts

- **NCT ID:** NCT04216849
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2020-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04216849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04216849, "Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04216849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*